Positive Late-Stage Data Reported for Enzalutamide (Xtandi) in Men With Metastatic Prostate Cancer

Positive results have been reported from a phase III trial of enzalutamide in patients with chemotherapy-naive metastatic prostate cancer who had failed androgen-deprivation therapy and had few or no symptoms.

http://ift.tt/1feApuB